President Joe Biden’s declaration of support for the suspension of intellectual property rights on Covid-19 vaccines is a major, even unprecedented step. But it doesn’t guarantee what sort of waivers will eventually be negotiated—or when.For one thing, the US’ decision is insufficient by itself. The World Trade Organization (WTO), where the waivers will be hammered out, requires unanimous approval from its members, and at least one major bloc of wealthy nations—the European Union—is as yet undecided. The EU and the US have been at the forefront of blocking such waivers in the past, not least because the world’s major drug companies—and their lobbying budgets—are based in these countries.What
Hence then, the article about the us support for vaccine patent waivers still leaves plenty to be resolved was published today ( ) and is available onQuartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( The US’ support for vaccine patent waivers still leaves plenty to be resolved )